Macquarie Group’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-132
| Closed | -$24K | – | 2394 |
|
|
2022
Q3 | $24K | Sell |
132
-539
| -80% | -$98K | ﹤0.01% | 2145 |
|
|
2022
Q2 | $20K | Hold |
671
| – | – | ﹤0.01% | 2315 |
|
|
2022
Q1 | $21 | Sell |
671
-2,843
| -81% | -$89 | ﹤0.01% | 2374 |
|
|
2021
Q4 | $110K | Hold |
3,514
| – | – | ﹤0.01% | 1910 |
|
|
2021
Q3 | $54K | Buy |
3,514
+2,975
| +552% | +$45.7K | ﹤0.01% | 2202 |
|
|
2021
Q2 | $10K | Hold |
539
| – | – | ﹤0.01% | 2472 |
|
|
2021
Q1 | $10K | Sell |
539
-256
| -32% | -$4.75K | ﹤0.01% | 2394 |
|
|
2020
Q4 | $12K | Hold |
795
| – | – | ﹤0.01% | 2291 |
|
|
2020
Q3 | $9K | Hold |
795
| – | – | ﹤0.01% | 2293 |
|
|
2020
Q2 | $10K | Buy |
+795
| New | +$10K | ﹤0.01% | 2292 |
|
|
2018
Q1 | – | Sell |
-3,300
| Closed | -$9K | – | 2380 |
|
|
2017
Q4 | $9K | Buy |
+3,300
| New | +$9K | ﹤0.01% | 2283 |
|